These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26301474)

  • 1. Intravenous Artesunate for the Treatment of Severe and Complicated Malaria in the United States: Clinical Use Under an Investigational New Drug Protocol.
    Twomey PS; Smith BL; McDermott C; Novitt-Moreno A; McCarthy W; Kachur SP; Arguin PM
    Ann Intern Med; 2015 Oct; 163(7):498-506. PubMed ID: 26301474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artesunate: investigational drug for the treatment of severe falciparum malaria in Hawai'i.
    Callender DM; Hsue G
    Hawaii Med J; 2011 Apr; 70(4):77-9. PubMed ID: 21785506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous artesunate for the treatment of severe malaria.
    Hess KM; Goad JA; Arguin PM
    Ann Pharmacother; 2010; 44(7-8):1250-8. PubMed ID: 20551300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia.
    Osorio L; Gonzalez I; Olliaro P; Taylor WR
    Malar J; 2007 Feb; 6():25. PubMed ID: 17328806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of artesunate and quinine in the treatment of severe Plasmodium falciparum malaria at Kassala hospital, Sudan.
    Abdallah TM; Elmardi KA; Elhassan AH; Omer MB; Elhag MS; Desogi MA; Siddig MF; Adam I
    J Infect Dev Ctries; 2014 May; 8(5):611-5. PubMed ID: 24820465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Effectiveness of Intravenous Artesunate for Treatment of Severe Malaria in the United States-April 2019 Through December 2020.
    Abanyie F; Acharya SD; Leavy I; Bowe M; Tan KR
    Clin Infect Dis; 2021 Dec; 73(11):1965-1972. PubMed ID: 34314501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe
    Shah PJ; Koshy J; Everett N; Attia E
    J Pharm Pract; 2020 Feb; 33(1):108-112. PubMed ID: 29898630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective comparative study of knowlesi, falciparum, and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax but no mortality with early referral and artesunate therapy.
    Barber BE; William T; Grigg MJ; Menon J; Auburn S; Marfurt J; Anstey NM; Yeo TW
    Clin Infect Dis; 2013 Feb; 56(3):383-97. PubMed ID: 23087389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Published reports of delayed hemolytic anemia after treatment with artesunate for severe malaria--worldwide, 2010-2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Jan; 62(1):5-8. PubMed ID: 23302816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed haemolysis secondary to treatment of severe malaria with intravenous artesunate: Report on the experience of a referral centre for tropical infections in Spain.
    Aldámiz-Echevarría Lois T; López-Polín A; Norman FF; Monge-Maillo B; López-Vélez R; Perez-Molina JA
    Travel Med Infect Dis; 2017; 15():52-56. PubMed ID: 27818359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study.
    Held J; Supan C; Salazar CL; Tinto H; Bonkian LN; Nahum A; Moulero B; Sié A; Coulibaly B; Sirima SB; Siribie M; Otsyula N; Otieno L; Abdallah AM; Kimutai R; Bouyou-Akotet M; Kombila M; Koiwai K; Cantalloube C; Din-Bell C; Djeriou E; Waitumbi J; Mordmüller B; Ter-Minassian D; Lell B; Kremsner PG
    Lancet Infect Dis; 2015 Dec; 15(12):1409-19. PubMed ID: 26342427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial.
    Sagara I; Beavogui AH; Zongo I; Soulama I; Borghini-Fuhrer I; Fofana B; Camara D; Somé AF; Coulibaly AS; Traore OB; Dara N; Kabore MJ; Thera I; Compaore YD; Sylla MM; Nikiema F; Diallo MS; Dicko A; Gil JP; Borrmann S; Duparc S; Miller RM; Doumbo OK; Shin J; Bjorkman A; Ouedraogo JB; Sirima SB; Djimdé AA
    Lancet Infect Dis; 2016 Feb; 16(2):189-98. PubMed ID: 26601738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
    Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
    Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous artesunate for severe malaria in travelers, Europe.
    Zoller T; Junghanss T; Kapaun A; Gjorup I; Richter J; Hugo-Persson M; Mørch K; Foroutan B; Suttorp N; Yürek S; Flick H
    Emerg Infect Dis; 2011 May; 17(5):771-7. PubMed ID: 21529383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Pharmacology of Antimalarial Drugs--First AHRO International Malaria Symposium.
    Kurtzhals J
    IDrugs; 2008 Oct; 11(10):713-5. PubMed ID: 18828068
    [No Abstract]   [Full Text] [Related]  

  • 16. Artesunate suppositories versus intramuscular artemether for treatment of severe malaria in children in Papua New Guinea.
    Karunajeewa HA; Reeder J; Lorry K; Dabod E; Hamzah J; Page-Sharp M; Chiswell GM; Ilett KF; Davis TM
    Antimicrob Agents Chemother; 2006 Mar; 50(3):968-74. PubMed ID: 16495259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed-onset hemolytic anemia in patients with travel-associated severe malaria treated with artesunate, France, 2011-2013.
    Jauréguiberry S; Thellier M; Ndour PA; Ader F; Roussel C; Sonneville R; Mayaux J; Matheron S; Angoulvant A; Wyplosz B; Rapp C; Pistone T; Lebrun-Vignes B; Kendjo E; Danis M; Houzé S; Bricaire F; Mazier D; Buffet P; Caumes E;
    Emerg Infect Dis; 2015 May; 21(5):804-12. PubMed ID: 25898007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No Reduction in Hemoglobin Level in Severe Plasmodium falciparum Malaria Treated with Artesunate in Central Sudan.
    Eltahir HG; Bilal JA; Ali EA; Adam I
    J Trop Pediatr; 2017 Feb; 63(1):18-22. PubMed ID: 27370816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda.
    Gasasira AF; Kamya MR; Achan J; Mebrahtu T; Kalyango JN; Ruel T; Charlebois E; Staedke SG; Kekitiinwa A; Rosenthal PJ; Havlir D; Dorsey G
    Clin Infect Dis; 2008 Apr; 46(7):985-91. PubMed ID: 18444813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemolysis associated with the treatment of malaria with artemisinin derivatives: a systematic review of current evidence.
    Rehman K; Lötsch F; Kremsner PG; Ramharter M
    Int J Infect Dis; 2014 Dec; 29():268-73. PubMed ID: 25448338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.